Приказ основних података о документу

long noncoding rna gaS as a new biomarker in oncology

dc.contributorPavlović, Sonja
dc.contributorBegović, Jelena
dc.contributorNovaković, Ivana
dc.contributorSavić Pavićević, Dušanka
dc.contributorĐorđević, Ana
dc.creatorGašić, Vladimir
dc.creatorTošić, Nataša
dc.date.accessioned2023-02-14T13:17:02Z
dc.date.available2023-02-14T13:17:02Z
dc.date.issued2021
dc.identifier.issn2787-2947
dc.identifier.urihttps://imagine.imgge.bg.ac.rs/handle/123456789/1727
dc.description.abstractGrowth arrest specific 5 (GAS5) je duga nekodirajuća RNK koja zaustavlja ćelijski ciklus i promoviše apoptozu. Ponašajući se kao signalni protein, kao mamac za druge molekule ili kao transportni molekul, ova regulatorna RNK utiče na niz puteva i molekula koji su bitni za rast ćelije i apoptozu, među kojima se ističu p53 mreža, mTOR signalni put, AKT signalni put, kao i molekuli mikro RNK, PTEN i slični. Brojne studije na različitim tipovima karcinoma su pokazale da nivo ekspresije GAS5 utiče na razvoj i tok bolesti kod hematoloških maligniteta, ginekoloških karcinoma, glioma, karcinoma dojke, karcinoma gastrointestinalnog trakta, bubrega, bešike, prostate i pluća. Shodno tome, GAS5 je novi biomarker u onkologiji, koji ima dijagnostički i prognostički značaj.sr
dc.description.abstractGrowth arrest specific 5 (GAS5) is a long noncoding RNA which halts the cell cycle and promotes apoptosis. Acting as a signal protein, as a decoy for other molecules or as a transport molecule, this regulatory RNA influences a number of pathways and molecules relevant for the growth of the cell and apoptosis, among them the most important being the p53 network, the mTOR signal pathway, the AKT signal pathway, as well as molecules of microRNA, PTEN and others. Numerous studies on diverse cancer types have confirmed that the expression of GAS5 influences the development and the course of hematological malignancies, gynecologic carcinoma, gliomas, breast cancer, gastrointestinal cancer, kidney cancer, bladder cancer, prostate cancer and lung cancer. Therefore, GAS5 is a promising new diagnostic and prognostic biomarker in oncology.sr
dc.language.isosrsr
dc.publisherBeograd : Institut za molekularnu genetiku i genetičko inženjerstvosr
dc.relationinfo:eu-repo/grantAgreement/MESTD/inst-2020/200042/RS//sr
dc.rightsopenAccesssr
dc.sourceTrendovi u molekularnoj Biologijisr
dc.subjectduga nekodirajuća RNKsr
dc.subjectGAS5sr
dc.subjectbiomarkersr
dc.subjectkarcinomisr
dc.subjectlong noncoding RNAsr
dc.subjectbiomarkerssr
dc.subjectcancerssr
dc.titleDuga nekodirajuća rnk gaS kao novi biomarker u onkologijisr
dc.titlelong noncoding rna gaS as a new biomarker in oncologysr
dc.typebookPartsr
dc.rights.licenseARRsr
dc.citation.epage122
dc.citation.spage113
dc.identifier.fulltexthttps://imagine.imgge.bg.ac.rs/bitstream/id/77426/Long_noncoding_rna_gaS_as_a_new_biomarker_in_oncology_2021.pdf
dc.identifier.rcubhttps://hdl.handle.net/21.15107/rcub_imagine_1727
dc.type.versionpublishedVersionsr


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу